Aspen Grove Capital’s Strata Critical Medical Inc SRTA Stock Holding History

Aspen Grove Capital’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523K	Hold	125,000	–	–	0.1%	97
2025 Q4	$601K	Hold	125,000	–	–	0.1%	89
2025 Q3	$633K	Hold	125,000	–	–	0.11%	84
2025 Q2	$504K	Hold	125,000	–	–	0.09%	110
2025 Q1	$341K	Hold	125,000	–	–	0.07%	144
2024 Q4	$531K	Hold	125,000	–	–	0.11%	100
2024 Q3	$368K	Hold	125,000	–	–	0.08%	126
2024 Q2	$435K	Hold	125,000	–	–	0.1%	115
2024 Q1	$356K	Hold	125,000	–	–	0.1%	124
2023 Q4	$441K	Hold	125,000	–	–	0.13%	95
2023 Q3	$324K	Hold	125,000	–	–	0.12%	112
2023 Q2	$493K	Hold	125,000	–	–	0.16%	114
2023 Q1	$423K	Hold	125,000	–	–	0.18%	96
2022 Q4	$448K	Buy	+125,000	New	+$534K	0.21%	87

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aspen Grove Capital's SRTA Position: Q1 2026 in Review

Aspen Grove Capital held its Strata Critical Medical Inc (SRTA) position steady in Q1 2026 at 125,000 shares worth $523K. The position accounts for 0.1% of the portfolio, ranked #97.

Aspen Grove Capital first reported a position in SRTA in Q4 2022 and has held it in 14 quarters since. The position peaked at $633K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

Aspen Grove Capital held 125,000 shares of Strata Critical Medical Inc worth $523K as of Q1 2026.
Aspen Grove Capital left its Strata Critical Medical Inc share count unchanged in Q1 2026.
Strata Critical Medical Inc made up 0.1% of Aspen Grove Capital's portfolio in Q1 2026, its #97 holding.
Aspen Grove Capital first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 14 quarters since.
Aspen Grove Capital's Strata Critical Medical Inc position peaked at $633K in Q3 2025.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Aspen Grove Capital's 13F filing for Q1 2026, filed 14 May 2026.